Lanean...

小细胞肺癌驱动基因研究进展

Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains dismal. Screening for the targetable driver mutations of this malignant tumor contributes to improve the therapeutic approaches and outcome. This review will report the advances on some latest driver mutations.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Zhongguo Fei Ai Za Zhi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 中国肺癌杂志编辑部 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5999810/
https://ncbi.nlm.nih.gov/pubmed/27118653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2016.04.10
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!